 Home > Medical News > Latest Medical News > Hengrui Class 1 new drug is close to NDA, what signals have it released

Hengrui Class 1 new drug is close to NDA, what signals have it released

 Last Update: 2021-07-28
 Source: Internet
 Author: User

Tags

what meaning metabolism

what docosanol

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

reference

1.
Yaozhi data

2.
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models.
Cancer Science.
2019.
DOI: 10.
1111/cas.
13957

3.
Study on the anti-RB positive tumor activity of CDK4/6 inhibitor SHR6390.

4.
Information on the official website of Jiangsu Hengrui

5.
Hengrui Pharmaceutical Official WeChat

6.
http://

7.
ASCO Information Report (2020)

Editor in charge: Listen to the white

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.